Pruriginous vesicular eruption associated with nivolumab immunotherapy: A case of dermatitis herpetiformis

Ann Dermatol Venereol. 2024 Jun;151(2):103269. doi: 10.1016/j.annder.2024.103269. Epub 2024 Apr 27.

Authors

M Housset¹, A Fayad Kazour², C Paugam², Y Le Corre², A Croue³, L Martin², D Lechevalier², C Berthin²

Affiliations

¹ Department of Dermatology, 4 rue Larrey, 49100 Angers, France. Electronic address: housset.marie.clementine@gmail.com.
² Department of Dermatology, 4 rue Larrey, 49100 Angers, France.
³ Department of Pathology, 4 rue Larrey, 49100 Angers, France.

PMID: 38678772
DOI: 10.1016/j.annder.2024.103269

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / adverse effects
Dermatitis Herpetiformis* / chemically induced
Drug Eruptions / etiology
Drug Eruptions / pathology
Female
Humans
Male
Nivolumab* / adverse effects
Pruritus / chemically induced

Substances

Nivolumab
Antineoplastic Agents, Immunological